Donor T cells support both engraftment and immune reconstitution after allogeneic BMT. Moreover, they may exert potent anti-tumor effects (graft-versus-leukemia, GVL), which are used for adoptive immunotherapy. On the other hand, infusion of allogeneic T cells is frequently associated with the manifestation of immune reactions against healthy tissue, which may lead to lifethreatening graft-versus-host disease (GVHD). To overcome this problem, we developed a new strategy for the exclusive depletion of alloreactive cells from donor leukocytes. We activated donor T cells by co-cultivation with a stroma layer of recipient cells and analyzed activation kinetics of CD3 ؉ , CD4 ؉ and CD8 ؉ T cells. Based on these data, activated cells were then depleted based on expression of activation-induced antigens using magnetic cell sorting (MACS). Alloreactivity of donor T cells was remarkably decreased after depletion of cells expressing either CD25 or CD69, as was shown in suitable in vitro assays. The lowest level of alloreactivity was found when both CD25-and CD69-positive cells were depleted. Importantly, depleted cell fractions preserved reactivity against third-party cells. In summary, we found that MACS-based ex vivo depletion of alloreactive cells may be a suitable way to prevent GVHD and therefore improve allogeneic BMT and adoptive immunotherapy. Bone Marrow Transplantation (2000) 25, Suppl. 2, S39-S42.
Donor T cells co-infused during allogeneic bone marrow transplantation may cause severe, potentially lethal graftversus-host disease (GVHD). On the other hand, depletion of allogeneic T cells has been associated with impaired engraftment, delayed immune reconstitution and higher relapse incidence. 1 The latter observation is due to the socalled graft-versus-leukemia (GVL) effect, which has been linked with immunological recognition of leukemic cells by donor T cells. This effect already proposed more than Correspondence: Dr B Fehse, Bone Marrow Transplantation, University Hospital Eppendorf, Martinistr. 52, 20251 Hamburg, Germany 40 years ago by Barnes and Loutit has been well established for about 10 years. 1 It became even more evident after the first successful treatment of hematological malignancies by the infusion of donor leukocytes (DLI). 2 Infusion of immunocompetent cells referred to as adoptive immunotherapy has become a treatment option for different malignancies and viral infections, [1] [2] [3] although the risk of GVHD still remains. Consequently, many efforts have been directed toward the separation of the wanted (ie GVL, protection against infections) from the unwanted immune reactions (ie GVHD), especially after strong antileukemic reactions were reported in the absence of acute GVHD. 1 Several studies have been based on the depletion of defined T cell subsets (eg CD4, CD5, CD6, CD8), using monoclonal antibodies (AB). 1, 4 However, controversial results regarding the usefulness of depletion of one or the other T cell subpopulations have been reported. Alternatively, ex vivo activation of alloreactive T cells and elimination of CD25 (= IL-2 receptor ␣-chain)-expressing cells using immunotoxins has been suggested. 5 Also, a gene therapeutic approach has been proposed based on genetically modified T cells expressing a so-called suicide gene to allow their later elimination. 6 All these strategies have been the subject of clinical trials thus underlining the importance of the problem.
We have developed a procedure which is directed towards the selective depletion of alloreactive donor cells based on expression of activation-induced antigens. Our approach relies on magnetic cell sorting (MACS) instead of immunotoxin-mediated killing. We activated T cells on stroma cell layers derived from allogeneic PBMNC and subsequently depleted cells expressing CD25, CD69 or both activation-induced antigens. We show here that alloreactive cells could be efficiently eliminated using this approach. Depleted cells conserve their potential against third-party cells.
Materials and methods

Primary cells, cell lines and generation of stroma layers
MNC were isolated from healthy donor blood as described. 7 If not stated otherwise, primary cells were cultivated in RPMI 1640-based T cell medium. 7 CTLL-2 cells were kept as described. 8 CD4 and/or CD8 cells were enriched using CD4 and CD8 MicroBeads (Miltenyi Biotec, BergischGladbach, Germany) according to the manufacturer's protocol. To establish stroma layers, PBMNC were cultivated in the presence of 100 U/ml IL-4 and 500 U/ml GM-CSF for 24 h. Non-adherent cells were removed. Further cultivation for 8-14 days led to the development of a confluent cell layer.
Stimulation, detection and depletion of alloreactive T cells
For stimulation, PBMNC cells were co-cultivated with allogeneic cells for up to 72 h. Cells were then harvested and incubated with ␣-CD3-FITC + ␣-CD25-PE or ␣-69-PE ABs. The percentage of allo-activated T cells was determined at different time points by flow cytometry on a FACScan (Becton Dickinson, San Jose, CA, USA). 9 For depletion, cells were harvested, washed and subsequently incubated with ␣-CD25 and/or ␣-CD69 ABs in MACS buffer 9 at 4°C for 30 min. After washing, cells were marked with a secondary, magnetic bead-coupled ␣-IgG 1 -AB (Miltenyi). 9 The VarioMACS-system and AS depletion columns (both Miltenyi) were used for depletion according to the manufacturer's instructions. To determine the efficacy of depletion, samples of positive and negative cells were analyzed by flow cytometry immediately and/or 24 h after depletion.
Mixed lymphocyte cultures and HTLPf
Stimulator cells were treated with mitomycin C to block proliferation. Then, 10 4 cells/well of a 96-well plate were incubated with 10 4 cells from different samples of 'donor' cells (before and after depletion). After 72 h proliferation of donor cells was determined using a 3 H-TdR-incorporation assay as described. 8 The HTLPf assay designed to determine the frequency of antigen-specific helper T lymphocyte precursor cells was carried out as described. 5 
Results
Activation kinetics of alloreactive T cells on stroma layers
First, we investigated the activation kinetics of allogeneic T cells on stroma cell layers derived from peripheral blood mononuclear cells (PBMNC) based on the expression of activation antigens CD25, CD69, CD40L and CD71. We found that co-cultivation with adherent recipient cells leads to remarkable increased expression of the activation antigens CD25 and CD69 (Figure 1 ) on donor T cells, and a lower but significant increase of CD40L and CD71 (not shown). During allostimulation the highest number of specific CD69-positive cells was detected after 24 h and the highest number of CD25-positive cells after 72 h ( Figure  1) . Moreover, the mean fluorescence (MF) intensity characterizing antigen density on positive cells increased after allostimulation. This increase was estimated calculating the coefficient of MF after allostimulation vs control. This value peaked for CD25 expression after 24 h (1.5) and for CD69 expression after 72 h (2.3). Interestingly, we detected co-expression of CD25 and CD69 only on a small portion of the alloactivated cells (not shown).
To further specify which T cells are being activated in the presence of alloantigens, we used three-color flow cytometry for detection of surface antigens (CD3/4/25, CD3/4/69, CD3/8/25 and CD3/8/69). We found strong activation of CD4 + cells as characterized by both increased CD25 and CD69 expression. Activation of CD8 cells was mainly documented by increased expression of CD69. Similar data were obtained using pure populations of CD4 and CD8 cells obtained after magnetic cell sorting. However, in those experiments, hardly any CD25 expression could be detected on CD8 cells (data not shown). Most of the activated CD4
+ as well as CD8 + cells expressed either CD25 or CD69, but not both activation-induced antigens together (data not shown).
Depletion of activated T cells
We then tried to deplete activated T cells based on the expression of activation markers by magnetic cell sorting. We, therefore, used monoclonal antibodies against CD25 and CD69 either alone or in combination. Depletion of CD25-expressing T cells was much more efficient than CD69 depletion. Notably, the number of both CD25 and CD69-expressing cells in the 'depleted fraction' was decreased only by about one third after depletion of cells expressing the alternative antigen (not shown). However, co-depletion of cells expressing both antigens led to a remarkable reduction of both CD25-and CD69-expressing T cells. Remaining CD25 + and/or CD69 + cells showed only very low expression levels of the antigens in comparison to undepleted cell fractions (Figure 2 ).
Decreased alloreactivity after selective depletion of CD25-and CD69-expressing cells
We then carried out several in vitro assays commonly used for determining reactivity of T cells. First, we used mixed lymphocyte cultures (MLC) to determine the best time point for depletion of alloreactive cells if magnetic cell sorting was used. Based on our activation kinetics we chose 24 and 48 h as appropriate time points. We found a strong decrease of 3 H-TdR incorporation after depletion of CD25-positive cells, a less pronounced effect after depletion of CD69-positive cells, but the significantly strongest effect after co-depletion of both CD25 and CD69 positive cells. Depletion was most effective 48 h after alloactivation (data not shown). Co-cultivation of allodepleted cells with mitomycin-treated third-party cells led to a strong increase of proliferation, although 3 H-TdR incorporation was reduced in comparison to non-depleted cells (not shown). Next, we carried out HTLPf assays in order to determine alloreactivity of donor T cells on a clonal level. Typical results of Figure 2 Efficient depletion of alloreactive cells using magnetic cell sorting. Peripheral MNC were allo-activated for 48 h as described and analyzed for CD25 (b) and CD69 expression (f). Activated cells were depleted by magnetic cell sorting using either anti-CD25 (c), anti-CD69 (g) or both AB in combination (d, h) . Expression of activation-induced antigens CD25 (b-d) and CD69 (f-h) was analyzed by flow cytometry 24 h after depletion. Depletion was much more efficient for CD25-expressing cells (Ͼ99%) than for CD69-expressing cells (85% in case of co-depletion). In (a) the position of the lymphogate used for analysis is indicated; (e) represents an IgG 1 isotype control.
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two such experiments are shown in Figure 3 . We found a strong reduction in the frequency of recipient-specific T helper clones after depletion of both CD25-and CD69-positive cells. Depletion of CD25-or CD69-positive cells alone also led to reduced frequencies of alloreactive clones, but to a significantly lower extent (Figure 3) . In all cases, the number of alloreactive clones directed against thirdparty cells was only slightly decreased (not shown).
Discussion
Infusion of donor T cells proven to exert potent anti-leukemic and anti-viral activity is associated with the risk of GVHD a potentially life-threatening complication. [1] [2] [3] 5 Figure 3 Depletion of CD25-and CD69-expressing cells led to decreased activity in HTLPf assay. Cells were activated for 48 h on allogeneic stroma cells and depleted as described (Figure 2) . Subsequently, different cell fractions were analyzed in HTLPf assays. The frequency of alloreactive helper T lymphocyte precursors is strongly decreased after depletion of both CD25-and CD69-expressing cells. The strongest effect is seen after combined depletion. Representative results from two independent experiments are shown.
Here, we used magnetic cell sorting to selectively deplete allo-activated donor T cells. We have shown that this technique allows highly efficient depletion of CD25-expressing and acceptable depletion of CD69-expressing cells. This is in agreement with recently published data. 10, 11 In comparison with other techniques such as immunotoxin-mediated killing of alloactivated donor cells 5 or fluorescence activated cell sorting (FACS), 12 magnetic cell sorting has several advantages including good recovery rates, the high potential for clinical use based on existing clinical devices and low toxicity for untouched cells. 10, 11 The use of a stroma cell layer for alloactivation ensures efficient presentation of both class 1 and class 2 MHC antigens by dendritic cells. 13 Indeed, we found that various activation-induced antigens such as CD25, CD69, CD71 or CD40L are up-regulated during co-cultivation. Because of their strong induction, CD25 and CD69 antigens seemed to be most suitable for depletion after 48 h of allo-activation. Interestingly, only small portions of allo-activated T cells expressed both CD25 and CD69 simultaneously at any time of co-cultivation. Data obtained with purified CD4 and CD8 cells confirmed these results indicating that CD25 and CD69 may, at least partly, represent different activation pathways. In fact, we found that co-depletion of both CD25 and CD69 cells is significantly superior to depletion of either CD25-or CD69-expressing cells alone. Remaining alloreactivity seen in our study may be due to non-sufficient depletion of CD69-expressing cells, as also reported by Koh et al 10 or different activation kinetics of various T cell clones. To overcome this limitation, we propose the combined use of antibodies directed against several activationinduced markers (eg CD25, CD40L, CD69, CD71, HLA-DR, CD95L) representing different states of activation and, possibly, different activation pathways.
